Skip to Content
Merck
CN
  • Alteration of bile acid metabolism in pseudo germ-free rats [corrected].

Alteration of bile acid metabolism in pseudo germ-free rats [corrected].

Archives of pharmacal research (2012-12-06)
Salil Kumar Bhowmik, Ji Hye An, Soo Hyun Lee, Byung Hwa Jung
ABSTRACT

To characterize the impact of gut microbiota on host bile acid metabolism, we investigated the metabolic profiles of oxysterols and bile acids (BAs) in a conventional rat model (SD) (n=5) and its pseudo germ-free (GF) equivalent (n=5). GF rats were developed by the oral administration of bacitracin, neomycin and streptomycin (200 mg/kg, each) twice a day for 6 days. Urinary levels of oxysterols and bile acid metabolites were quantified using gas chromatography-mass spectrometry (GC-MS). The activity levels of enzymes involved in the bile acid metabolic pathway were determined through urinary concentration ratio between product to precursor. Cholic acid (CA) and α-/β-muricholic acid (α-/β-MCA) were significantly elevated at pseudo germ-free condition. An increase of hydroxylase (cholesterol 7α-hydroxylase, oxysterol 7α-hydroxylase and cytochrome P450 scc) and a significant decrease of 7α-dehydroxylase were observed. The urinary concentration ratio of primary bile acids, a marker for hepatotoxicity, increased in pseudo germfree conditions. Therefore, it was found that gut microbiota could play a significant role in the bile acids homeostasis and metabolism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cholic acid, from bovine and/or ovine, ≥98%
Sigma-Aldrich
Bacitracin zinc salt, from Bacillus licheniformis, ~70,000 U/g
Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder, BioReagent, suitable for cell culture
Cholic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Cholic acid, Vetec, reagent grade, 98%